$1.90 per share is a huge premium to pay for 21% of the company. Makes the current trading price look like the bargin of the year.Who bought the shares - was it Impala Platinum.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor